Detalhe da pesquisa
1.
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
Oncologist
; 25(11): 954-962, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812320
2.
RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samples.
PLoS One
; 18(10): e0293400, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883360
3.
Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-ß-trap bifunctional antibody, in patients with advanced solid tumors.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746510
4.
Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b study.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34992093
5.
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma.
Sci Rep
; 12(1): 11007, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35773363
6.
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival.
J Immunother Cancer
; 9(12)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893523
7.
Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
J Cell Biochem
; 103(2): 624-35, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17562544
8.
Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth.
Mol Cancer Ther
; 5(4): 1079-86, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16648580
9.
Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.
Prostate
; 68(11): 1232-40, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18491370
10.
Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs.
Bioorg Med Chem Lett
; 17(14): 4026-9, 2007 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17502145
11.
Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.
Breast Cancer Res Treat
; 94(1): 37-46, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16142439